PMID: 6989695Mar 1, 1980Paper

Characterization of insulin receptors in patients with the syndromes of insulin resistance and acanthosis nigricans

Diabetologia
R S BarJ Roth

Abstract

This report analyzes the in vitro characteristics of 125I-insulin binding to the monocytes of nine patients with the syndromes of acanthosis nigricans and insulin resistance. The 3 Type A patients (without demonstrable autoantibodies to the insulin receptor) had decreased binding of insulin due to a decreased concentration of receptors. In these patients the residual receptors demonstrated normal dissociation kinetics, negative cooperativity, and were blocked by anti-receptor antibodies in a manner similar to normal cells. In contrast, monocytes from the 6 Type B patients (with circulating anti-receptor autoantibodies) had decreased binding of insulin due to a decrease in receptor affinity. Insulin binding to monocytes of Type B patients demonstrated accelerated rates of dissociation with no evidence of cooperative interactions among insulin receptors. When coupled with previous data, the present studies further suggest that different mechanisms account for the defects in insulin binding and insulin resistance observed in these patients.

References

Oct 1, 1975·The Journal of Clinical Investigation·A H SoliJ Roth
Apr 1, 1976·The New England Journal of Medicine·C R KahnJ Roth
May 1, 1976·The Journal of Clinical Investigation·J M Olefsky
Jun 1, 1977·The Journal of Clinical Endocrinology and Metabolism·R S BarC W Siebert
Oct 1, 1979·Proceedings of the Society for Experimental Biology and Medicine·J RothP Gorden
Jul 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·M KobayashiA H Rubenstein
Sep 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·C R KahnJ S Flier
Jul 1, 1978·The Journal of Clinical Investigation·R A DeFronzoP Felig
Sep 1, 1978·The Journal of Clinical Endocrinology and Metabolism·R S BarJ Imperato-McGinley
Jan 1, 1979·The Journal of Clinical Endocrinology and Metabolism·M MuggeoP Gorden
May 25, 1978·The New England Journal of Medicine·R S BarM Muggeo
Mar 1, 1979·The New England Journal of Medicine·M MuggeoC R Kahn
May 1, 1977·Annals of Internal Medicine·W G BlackardF Mullinax
Dec 1, 1976·The Journal of Clinical Investigation·J S FlierJ Roth
Nov 1, 1976·Proceedings of the National Academy of Sciences of the United States of America·D B JarrettJ S Flier
Jan 1, 1975·The Journal of Clinical Investigation·J A ArcherJ Roth
Oct 27, 1975·Biochemical and Biophysical Research Communications·P De Meyts, J Roth
Feb 9, 1972·Nature: New Biology·J W HaddenR G Coffey

❮ Previous
Next ❯

Citations

Jan 1, 1983·Human Genetics·H W Rüdiger, M Dreyer
Jan 1, 1982·Springer Seminars in Immunopathology·L C Harrison
Jun 1, 1981·Molecular and Cellular Endocrinology·E Van Obberghen, C R Kahn
Mar 1, 1987·Molecular and Cellular Endocrinology·A P BautistaA Volkman
Dec 2, 1982·The New England Journal of Medicine·S I TaylorP Gorden
Nov 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·S I TaylorM J Elders
Feb 1, 1992·Clinical Endocrinology·S O'Rahilly, D E Moller
Apr 1, 1994·Acta Paediatrica. Supplement·S I TaylorE Wertheimer
Apr 5, 1986·British Medical Journal·R Taylor
Dec 1, 1985·The Journal of Clinical Investigation·J A HedoS I Taylor
Jan 1, 1989·Critical Reviews in Biochemistry and Molecular Biology·Y Zick
Sep 1, 1986·Metabolism: Clinical and Experimental·E J PetersM J Prince
Jan 17, 1983·The American Journal of Medicine·R S Bar
Mar 1, 1986·Metabolism: Clinical and Experimental·C A StuartW J Meyer
Jan 1, 1985·Diabetes/metabolism Reviews·S I Taylor
Nov 1, 1984·International Journal of Dermatology·R G Sibbald, R K Schachter
Oct 1, 1988·Acta Paediatrica Japonica; Overseas Edition·T TakumiT Matsuo
Oct 1, 1988·Diabetic Medicine : a Journal of the British Diabetic Association·S S Reddy, C R Kahn
Sep 1, 1987·Journal of Adolescent Health Care : Official Publication of the Society for Adolescent Medicine·D C Moore
Apr 1, 1997·Pediatric Clinics of North America·N S Glaser
Mar 1, 1983·Clinics in Endocrinology and Metabolism·G GrunbergerP Gorden
Feb 20, 1999·The Diabetes Educator·B S FreelandD L Seal
Oct 1, 1988·Gastrointestinal Radiology·D D MaglinteJ L Lapeña
Feb 1, 1995·The Australian and New Zealand Journal of Surgery·K W EuH S Goh
Sep 1, 1990·Endocrine Pathology·Ara Chalvardjian
Apr 27, 2021·The Journal of Clinical Endocrinology and Metabolism·Isabel Huang-DoranRobert K Semple
Oct 1, 1986·Metabolism: Clinical and Experimental·Y TakataA Fujinami
Jul 1, 2021·National Journal of Maxillofacial Surgery·Sourabh Ramesh JoshiNeeta Padmawar

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.